Book a Demo
Elana Gotkine
Gray shield icon
Is this you?
Claim your profile.

Elana Gotkine

Medical And Scientific Writer

AS SEEN ON
HealthDay News, Drugs.com, Medical Xpress

Preston's Summary

Elana Gotkine is a Medical and Scientific Writer at Physician's Briefings. Originally from the U.K. and holding a Master's degree in Biological Natural Sciences from the University of Cambridge, Elana has extensive experience in medical and healthcare writing, focusing on topics such as public health, mental health care, and various medical specialties. She has been featured in outlets including Phys.org, HealthDay News, and Medical Xpress.

Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston

Geo Focus

United States (National)

Coverage Attributes:

Beta
Informative: 43 %
Data Driven: 37 %
Product Service Comparisons: 4 %
Opinion: 3 %
Promotional: 3 %

Themes Covered:

Not enough data icon

Not enough data

Most Recent Topics:

  • Public Health
  • Health News
  • Drugs & Medication
  • Mental Health Care
  • Dermatology
  • Oncology
  • Aging & Longevity
  • Diet & Nutrition

Pitching Insights

Elana's coverage predominantly focuses on scientific and healthcare topics, including medical research, diseases, health conditions, treatments, and advancements. She frequently cites data in her articles.

Given this focus, Elana is likely to be interested in pitches from experts who can provide insights into cutting-edge medical research or breakthroughs in the treatment of various health conditions. Pitches offering access to new data or studies could also be well-received by Elana.

As she doesn't have a specific geographic focus mentioned, it's important for potential sources to ensure that their expertise aligns with the global relevance of the topics covered rather than being region-specific.

This information evolves through artificial intelligence and human feedback. Improve this profile .

Journalists With Similar Coverage:

Based on similarity of content.
Todd Neale

Todd Neale

Associate News Editor, Senior Medical Journalist
*****e@******g
Publications
TCTMD, Gastroenterology Advisor, Endocrinology Advisor, Dermatology Advisor, Rheumatology Advisor
Most recent topics
Not enough data

Richard Smith

Medical Editor
*****h@*******om
Publications
Healio, Daily News-Sun, E3G, Hoodline, PETER DELLIOS, D.D.S., P.C
Most recent topics
Not enough data
Medha Baranwal

Medha Baranwal

Editor
Publications
Medical Dialogues
Most recent topics
Not enough data
Doug Brunk

Doug Brunk

Medical Writer
******66@*******om
Publications
Conexiant, MDEdge
Most recent topics
Not enough data
Mark Arredondo

Mark Arredondo

Publications
HealthDay News
Most recent topics
Not enough data
Hibah Khaja

Hibah Khaja

Principal Medical Writer
Publications
Neurology Advisor, Rheumatology Advisor, Pulmonology Advisor, Dermatology Advisor, The Clinical Advisor
Most recent topics
Not enough data

Articles

Medical Xpress

ADA: Once-weekly cagrilintide + semaglutide promising in type 2 diabetes

ADA: Once-weekly cagrilintide + semaglutide promising in type 2 diabetes

By: Elana Gotkine

Once-weekly cagrilintide, an amylin receptor agonist, plus semaglutide is efficacious for adults with type 2 diabetes inadequately controlled with diet and exercise, receiving metformin with or without a sodium glucose cotransporter 2 inhibitor (SGLT2i), and using basal insulin, according to three studies published online June 7 in The Lancet Diabetes & Endocrinology and The Lancet to coincide with the annual meeting of the American Diabetes Association, held from June 5 to 8 in New Orleans.

© 2026 Intelligent Relations